조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
제품정보 (DICE 배송 시 비용 별도)
실험식(Hill 표기법):
C18H19NOS · HCl
CAS 번호:
Molecular Weight:
333.88
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
제품 이름
(S)-Duloxetine hydrochloride, ≥98% (HPLC)
SMILES string
Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3
InChI key
BFFSMCNJSOPUAY-LMOVPXPDSA-N
InChI
1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1
assay
≥98% (HPLC)
form
powder
optical activity
[α]/D +116 to +125°, c = 1 in methanol
storage condition
desiccated
color
white to beige
solubility
H2O: 5 mg/mL (clear solution, warmed)
storage temp.
room temp
Quality Level
Gene Information
human ... SLC6A2(6530), SLC6A4(6532)
General description
(S)-Duloxetine hydrochloride belongs to the class of serotonin and norepinephrine reuptake inhibitors. Duloxetine is a thiophene derivative. It is used to treat stress urinary incontinence, psychiatric and metabolic disorders. It is also used for treating diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal and low back pain (LBP). Duloxetine is a cytochrome P450 2D6 (CYP2D6) inhibitor.
Application
(S)-Duloxetine hydrochloride has been used as an antidepressant in rats exposed to chronic mild stress (CMS).
Biochem/physiol Actions
Duloxetine hydrochloride is a dual serotonin/norepinephrine reuptake inhibitor (SNRI), widely used clinically as an antidepressant and anxiolytic.
Duloxetine hydrochloride is a dual serotonin/norepinephrine reuptake inhibitor (SNRI); antidepressant; anxiolytic.
Features and Benefits
This compound is featured on the Biogenic Amine Transporters page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Disclaimer
air sensitive
Hazard Classifications
Acute Tox. 4 Oral
signalword
Warning
hcodes
저장 등급
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
High-performance liquid chromatographic method for the simultaneous estimation of the key intermediates of duloxetine
Soni P, et al.
Talanta, 67(5), 975-978 (2005)
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain
Pergolizzi Jr JV, et al.
Pain Practice : The Official Journal of World Institute of Pain, 13(3), 239-252 (2013)
Mechanisms of pain transmission and pharmacologic management
Argoff C
Current Medical Research and Opinion, 27(10), 2019-2031 (2011)
Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats
Martin-Hernandez D, et al.
Neuropharmacology, 103(3), 79-91 (2016)
David Martín-Hernández et al.
Molecular neurobiology, 56(11), 7522-7533 (2019-05-06)
The standard pharmacological treatment of the major depressive disorder (MDD) is still grounded in a monoaminergic approach. Consequently, antidepressant treatments pursue to heighten serotonergic and noradrenergic neurotransmissions. Thus, the aim of this study was to assess the impact of exposure
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.